Wells Fargo Upgrades Tandem Diabetes Care to Overweight, Raises Price Target to $45

Tandem Diabetes Care, Inc. -2.89%

Tandem Diabetes Care, Inc.




Wells Fargo analyst Larry Biegelsen upgrades Tandem Diabetes Care (NASDAQ: TNDM) from Equal-Weight to Overweight and raises the price target from $21 to $45.
Every question you ask will be answered
Scan the QR code to contact us
Also you can contact us via